ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 766

Endothelial Fli1 Deficiency Delays Wound Healing Due to Impaired Anastomosis of Newly Formed Vessels – a Possible Mechanism of Refractory Skin Ulcers in Systemic Sclerosis

Yoshihide Asano1 and Maria Trojanowska2, 1Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 2Arthritis Center, Boston University, Boston, MA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, Animal models, Systemic sclerosis, transcription factor and wounds

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Systemic sclerosis (SSc) is a multisystem inflammatory and vascular disease resulting in fibrosis of the skin and certain internal organs. Although the pathogenesis of SSc still remains unknown, we have recently demonstrated that Fli1 deficiency at least partially due to epigenetic suppression contributes to the development of fibrosis and vasculopathy characteristically seen in this disease. A critical complication associated with SSc vasculopathy is refractory and recurrent skin ulcers which largely affect morbidity of SSc patients. To elucidate a potential mechanism rendering skin ulcers refractory to the treatments in SSc, we employed endothelial cell-specific Fli1 knockout (Fli1 ECKO) mice and carried out a wound healing experiment.

Methods

Fli1 ECKO mice were generated by crossing Fli1flox/flox mice with Tie2-Cre transgenic mice under a C57B/6 background. An 8 mm full-thickness skin wound was generated on the back of wild type (WT) and Fli1 ECKO mice with a punch biopsy. Vascular structure was visualized by FITC-dextran injection. The expression levels of target molecules were determined by immunohistochemistry in vivo and immunoblotting and quantitative reverse transcription-PCR in vitro using murine dermal microvascular endothelial cells (MDMECs). Promoter occupancy was evaluated by chromatin immunoprecipitation in MDMECs

Results

Wound healing was markedly delayed in Fli1 ECKO mice compared with WT mice. When vascular structure around scars was visualized with FITC-dextran injection, newly formed blood vessels were oriented toward the central area of scars in WT mice, while Fli1 ECKO mice lacked blood vessels around the central area of scars, suggesting that angiogenesis is impaired in Fli1 ECKO mice. At day 7 after wounding, many newly formed blood vessels filled with erythrocytes were present in granulation tissue in WT mice, while there were many dilated vessels with a few or no erythrocytes and a small number of vessels filled with erythrocytes in Fli1 ECKO mice. Since day 7 is a time point when newly formed blood vessels connect with pre-existing ones, it suggested that anastomosis may be impaired in Fli1 ECKO mice. In line with this idea, mRNA levels of the Notch1 and Dll4 genes, which code key molecules regulating anastomosis, were markedly decreased in ECs derived from Fli1 ECKO mice compared with those from WT mice. Furthermore, Fli1 occupied the promoter region of these genes in MDMECs.

Conclusion

Fli1 deficiency decelerates wound healing by inhibiting anastomosis of newly formed vessels with pre-existing ones and a similar process may contribute to the delayed wound healing associated with SSc.


Disclosure:

Y. Asano,
None;

M. Trojanowska,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/endothelial-fli1-deficiency-delays-wound-healing-due-to-impaired-anastomosis-of-newly-formed-vessels-a-possible-mechanism-of-refractory-skin-ulcers-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology